Search
Search results
432 results found
Camila Machado de Souza, MD
Nathaniel Camillo, MS, CRNA
Resident Wellness
Arpita Kulkarni, PhD
Introducing Dr. Arpita Kulkarni, Co-Director of the Functional Genomics and Bioinformatics Core at Beth Israel Deaconess Medical Center and Harvard Medical School, and an affiliate of the Broad Institute. Arpita is a cell and developmental biologist with deep expertise in functional genomics, single...
A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice.
Salwen-Deremer, Jessica K, Sarah Ballou, Megan Petrik, Miguel Regueiro, Corey A Siegel, Laurie Keefer, and GastroPsych Business Plan Working Group. 2025. “A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice.”. Gastroenterology.
Impact of Estrogen on Purinergic Signaling in Microvascular Disease.
Cassavaugh, Jessica, Maria Serena Longhi, and Simon C Robson. 2025. “Impact of Estrogen on Purinergic Signaling in Microvascular Disease.”. International Journal of Molecular Sciences 26 (5).
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.
Owings, Anna H, Sarah C Glover, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 70 (3): 1248-49.
Retraction notice to "Screening for novel central nervous system biomarkers in veterans with Gulf War Illness" [Neurotoxicology and Teratology 61 (2017) 36-46].
Abou-Donia, Mohamed B, Lisa A Conboy, Efi Kokkotou, Eric Jacobson, Eman M Elmasry, Passent Elkafrawy, Megan Neely, Cameron R Dale Bass, and Kimberly Sullivan. 2025. “Retraction Notice to ‘Screening for Novel Central Nervous System Biomarkers in Veterans With Gulf War Illness’ [Neurotoxicology and Teratology 61 (2017) 36-46].”. Neurotoxicology and Teratology 107: 107423.
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Papamichael, Konstantinos, and Adam S Cheifetz. 2025. “Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?”. Alimentary Pharmacology & Therapeutics 61 (2): 369-70.